AI assistant
Zai Lab Ltd — Director's Dealing 2021
Jan 4, 2021
31208_dirs_2021-01-04_51b34aef-ae7a-4aa7-99af-c5460625dfcd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Zai Lab Ltd (ZLAB)
CIK: 0001704292
Period of Report: 2021-01-01
Reporting Person: Reinhart Harald (Chief Medical Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.00 | 2027-05-12 | Ordinary Shares (33334) | Direct | |
| Stock Option (Right to Buy) | $18.00 | 2027-09-20 | Ordinary Shares (60000) | Direct | |
| Stock Option (Right to Buy) | $20.90 | 2028-03-28 | Ordinary Shares (100000) | Direct | |
| Stock Option (Right to Buy) | $17.99 | 2028-11-16 | Ordinary Shares (50000) | Direct |
Footnotes
F1: The option vests in equal annual installments over four years beginning on 05/12/2018, the first anniversary of the date of grant. The number in Column 3 represents the options that remain outstanding from the grant of 66,666 shares.
F2: The option vests in equal annual installments over five years beginning on 09/20/2018, the first anniversary of the date of grant. The number in Column 3 represents the options that remain outstanding from the grant of 100,000 shares.
F3: The option vests in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant.
F4: The option vests in equal annual installments over five years beginning on 11/16/2019, the first anniversary of the date of grant.